[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"radiosensitivity\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:radiosensitivity":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100518641","integrative-molecular-analysis-of-individual-radiosensitivity-in-pediatric-oncology-100518641",false,"NCT06033183","Integrative Molecular Analysis of Individual Radiosensitivity in Pediatric Oncology","FOCUSO","Inclusion Criteria:\n\n* Minor patient treated for a brain tumor, Ewing tumor, malignant mesenchymal tumor, neuroblastoma, nephroblastoma, Hodgkin's lymphoma treated with radiotherapy (+\u002F- chemotherapy) for curative purposes.\n* Children or adolescents \\> 3 years old and \\\u003C 18 years old\n* Patient with an indication for radiotherapy as part of the primary tumor local control strategy\n* Theoretical indication for radiotherapy in standard fractionation (1.8 Gy to 2.2 Gy \u002F fraction: 5 fr\u002Fweek) whatever the technique and the particle used\n* Patient affiliated with a social security scheme\n* Patient and\u002For parents or holders of parental authority having dated and signed an informed consent\n\nExclusion criteria:\n\n* Patients with contraindications to blood sampling\n* Patients with contraindications to radiotherapy\n* Palliative radiotherapy\n* Patient with previous RT treatment in the same area (re-irradiation)\n* Patient with an indication of hypofractionated RT\n* Patient follow-up not possible\n* Persons deprived of liberty or under guardianship (including curatorship)\n\nExclusion Criteria:\n\n\\-","ALL","3 Years","18 Years",{"count":20,"type":21},100,"ESTIMATED","INTERVENTIONAL",[24],"NA","Analysis of the individual radiosensitivity in pediatric oncology",[27,28,29],"Radiosensitivity","Pediatric Cancer","Radiation Toxicity","RECRUITING","2024-11-19",{"date":33,"type":34},"2024-11-22","ACTUAL",{"date":36,"type":34},"2023-12-02",{"date":38,"type":21},"2027-10-30",{"name":40,"class":41},"Neolys","INDUSTRY",2]